Paper
Preparation and characterization of dutasteride‐loaded nanostructured lipid carriers coated with stearic acid‐chitosan oligomer for topical delivery
Published Aug 1, 2017 · N. M. Noor, K. Sheikh, S. Somavarapu
European Journal of Pharmaceutics and Biopharmaceutics
Q1 SJR score
54
Citations
2
Influential Citations
Abstract
Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.
In Vitro StudyStudy Snapshot
Dutasteride-loaded nanostructured lipid carriers coated with stearic acid-chitosan oligomer conjugate show potential for topical delivery and hair growth promotion.
PopulationOlder adults (50-71 years)
Sample size24
MethodsObservational
OutcomesBody Mass Index projections
ResultsSocial networks mitigate obesity in older groups.
Sign up to use Study Snapshot
Consensus is limited without an account. Create an account or sign in to get more searches and use the Study Snapshot.
Full text analysis coming soon...
References
Histological assessment of follicular delivery of flutamide by solid lipid nanoparticles: potential tool for the treatment of androgenic alopecia
Flutamide-loaded solid lipid nanoparticles show promise as a promising colloidal drug carrier for topical administration of Flutamide in the treatment of androgenic alopecia.
2016·52citations·H. Hamishehkar et al.·Drug Development and Industrial Pharmacy
Drug Development and Industrial Pharmacy
Inverse micellar sugar glass (IMSG) nanoparticles for transfollicular vaccination.
Inverse micellar sugar glass nanoparticles (IMSG NPs) show potential for needle-free vaccination through the skin, with enhanced stability and encapsulation efficacy when co-encapsulated with an adjuvant.
2015·36citations·A. Mittal et al.·Journal of controlled release : official journal of the Controlled Release Society
Journal of controlled release : official journal of the Controlled Release Society
Enhanced skin permeation of 5α-reductase inhibitors entrapped into surface-modified liquid crystalline nanoparticles
Surface-modified liquid crystalline nanoparticles (sm-LCN) significantly enhance skin permeation of finasteride and dutasteride for treating androgenetic alopecia, potentially minimizing systemic side effects.
2015·17citations·Thiagarajan Madheswaran et al.·Archives of Pharmacal Research
Archives of Pharmacal Research
Squarticles as a Lipid Nanocarrier for Delivering Diphencyprone and Minoxidil to Hair Follicles and Human Dermal Papilla Cells
Squarticles, made from sebum-derived lipids, effectively deliver diphencyprone and minoxidil to hair follicles and dermal papilla cells, offering a promising nanocarrier for topical alopecia treatment.
2014·70citations·I. Aljuffali et al.·The AAPS Journal
The AAPS Journal
The efficacy and safety of 5α-reductase inhibitors in androgenetic alopecia: a network meta-analysis and benefit–risk assessment of finasteride and dutasteride
5-reductase inhibitors are effective and safe for treating androgenetic alopecia, with dutasteride 0.5 mg potentially becoming an additional treatment option after further study.
2014·78citations·Aditya K. Gupta et al.·Journal of Dermatological Treatment
Journal of Dermatological Treatment
Citations
Topical dutasteride for androgenic alopecia: current state and prospects.
Topical dutasteride shows potential as an effective and safe treatment for androgenic alopecia, reducing systemic side effects and focusing on hair follicles.
2024·0citations·Jayanaraian F M Andrade et al.·Therapeutic delivery
Therapeutic delivery
"Enhancing Oral Drug Absorption: Overcoming Physiological and Pharmaceutical Barriers for Improved Bioavailability".
Developing innovative drug delivery methods and overcoming physiological and pharmaceutical barriers can improve oral drug absorption, making it a preferred method for drug administration.
2024·1citation·Rashmi Maurya et al.·AAPS PharmSciTech
AAPS PharmSciTech
Theoretical design for covering Engeletin with functionalized nanostructure-lipid carriers as neuroprotective agents against Huntington’s disease via the nasal-brain route
A theoretical formulation of engeletin-nanostructured lipid nanocarriers may improve delivery and increase bioavailability of engeletin in treating Huntington's disease, potentially leading to a cure or prevention of this fatal illness.
2023·10citations·Smriti et al.·Frontiers in Pharmacology
Frontiers in Pharmacology
Nanotechnology-Based Strategies for Hair Follicle Regeneration in Androgenetic Alopecia
Nanotechnology holds great promise for developing effective and safe treatments for androgenetic alopecia, enhancing the bioavailability and efficacy of existing drugs and developing new therapeutic approaches.
2023·8citations·Zubair Saghir Ahmed Shaikh et al.·IOCN 2023
IOCN 2023
Boosting hair growth through follicular delivery of Melatonin through lecithin-enhanced Pickering emulsion stabilized by chitosan-dextran nanoparticles in testosterone induced androgenic alopecia rat model.
Lecithin-enhanced Pickering emulsion stabilized by chitosan-dextran nanoparticles effectively enhances photostability, antioxidant activity, and follicular delivery of Melatonin for treating androgenic alopecia.
2023·5citations·Asmaa A. Elshall et al.·International journal of pharmaceutics
International journal of pharmaceutics
A Full Factorial Design to Optimize Aminexil Nano Lipid Formulation to Improve Skin Permeation and Efficacy Against Alopecia
The optimized AMX-NLC formula A7 effectively promotes hair growth and reduces alopecia in chemotherapy-induced alopecia rats, with improved skin penetration and targeting.
2023·8citations·Amna M. A. Makky et al.·AAPS PharmSciTech
AAPS PharmSciTech
Impact of Parameter on Nanostructured Lipid Carrier Formulation and Approach of the Carrier for Cancer Treatment: a Brief Study
Nanostructured lipid carriers offer improved drug entrapment, bioavailability, stability, and targeted cancer treatment, but toxicity and biocompatibility must be studied for effective formulation and targeted cancer treatment.
2022·0citations·L. Sahoo et al.·Drug development & registration
Drug development & registration